Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Phelan-Mcdermid Syndrome. Data from NIH RePORTER, last 36 months.
Phelan-Mcdermid Syndrome has active NIH research funding with 10 funded grants totaling $12.8M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Phelan-Mcdermid Syndrome. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
2 funded grants in Translational / Drug Development but only 1 related publication found for Phelan-McDermid syndrome. This may indicate early-stage research that hasn't yet produced published results.
17 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for Phelan-McDermid syndrome. Existing research activity suggests this may be a viable area for grant applications.
6 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for Phelan-McDermid syndrome. Existing research activity suggests this may be a viable area for grant applications.
17 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for Phelan-McDermid syndrome. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Phelan-Mcdermid Syndrome as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.